Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 15, 2021

SELL
$228.69 - $274.2 $589,334 - $706,613
-2,577 Closed
0 $0
Q2 2021

Aug 16, 2021

SELL
$169.89 - $231.37 $906,533 - $1.23 Million
-5,336 Reduced 67.43%
2,577 $592,000
Q1 2021

May 17, 2021

BUY
$143.93 - $207.3 $1,871 - $2,694
13 Added 0.16%
7,913 $1.33 Million
Q3 2020

Nov 16, 2020

BUY
$90.16 - $107.61 $50,309 - $60,046
558 Added 7.6%
7,900 $780,000
Q2 2020

Aug 14, 2020

SELL
$52.17 - $95.63 $206,488 - $378,503
-3,958 Reduced 35.03%
7,342 $684,000
Q1 2020

May 15, 2020

BUY
$52.76 - $109.0 $84,416 - $174,400
1,600 Added 16.49%
11,300 $625,000
Q4 2019

Feb 14, 2020

BUY
$69.39 - $97.59 $103,807 - $145,994
1,496 Added 18.24%
9,700 $931,000
Q3 2019

Nov 14, 2019

SELL
$64.17 - $84.08 $449 - $588
-7 Reduced 0.09%
8,204 $581,000
Q2 2019

Aug 14, 2019

BUY
$70.1 - $85.17 $575,591 - $699,330
8,211 New
8,211 $699,000

Others Institutions Holding HSKA

About HESKA CORP


  • Ticker HSKA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 10,818,900
  • Description
  • Heska Corporation sells veterinary and animal health diagnostic and specialty products for canine and feline healthcare markets in the United States, Canada, Mexico, Australia, France, Germany, Italy, Malaysia, Spain, and Switzerland. The company offers Element DC, Element DCX, Element DC5x veterinary chemistry analyzers for blood chemistry and ...
More about HSKA
Track This Portfolio

Track Pdt Partners, LLC Portfolio

Follow Pdt Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pdt Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pdt Partners, LLC with notifications on news.